	Comparative efficacy and safety of first, second, and third-generation EGFR tyrosine kinase inhibitors in treatment-naÃ¯ve EGFR-mutant advanced non-small cell lung cancer: a systematic review and network meta-analysis of randomized controlled trials. J Egypt Natl Canc Inst Mahato S, Mudgal S, Singh H, Varikasuvu SR, Kumar H, Thankachan J, Kumar S. PMID: 42734867 [PubMed - indexed for MEDLINE]
	HRKHu-Loss: harmonic regularization Kullback Huber loss-based lung cancer detection and severity level classification using CT image. Eur Spine J Chennakesavan SA, Vijay M. PMID: 42734835 [PubMed - as supplied by publisher]
	Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy. N Engl J Med Zhao Y, Liu H, Meng X, Liu Z, Yu Y, Zheng Y, Sun L, Yang R, Liu J, Zhao Y, Wu L, Yang L, Zhang Z, Li M, Zhang P, Zhang Y, Zhong H, Cui J, Huang Z, Yin Y, Li M, Tong F, Xue D, Lv D, Li X, Zhang X, Chin S, Cai J, Xue T, Huang Y, Zhao H, Zhang L, TAISHAN-302 Investigators. PMID: 42734213 [PubMed - as supplied by publisher]
	Hemoptysis recurrence after arterial embolization in lung cancer: a 5-year retrospective cohort study. Diagn Interv Radiol Li H, Wu X. PMID: 42734046 [PubMed - as supplied by publisher]
	Carcinoembryonic Antigen Elevation in Bronchial Foreign Body Patients Initially Misdiagnosed as Lung Cancer. Clin Lab Zhai RQ, Liu JX, Yi GZ, Li YP, Guo FR, Wei SN, Pang SQ, Wang H, Wang XD, Yan QBCJJ. PMID: 42734004 [PubMed - indexed for MEDLINE]
	Natural language processing-based model to predict radiation pneumonitis in patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy: a retrospective cohort study. EClinicalMedicine Bloom JR, Tignor N, Van Vleck T, Mendoza DP, Tavolacci SC, Fankuchen O, Chun G, Chang S, Chung M, Tuminello S, Hirsch FR, Chachoua A, Sabari JK, Wisnivesky J, Cotarla I, Simmons D, Hsieh K, Tackaberry C, Rosenzweig KE, Samstein RM, Wang P, Veluswamy RR. PMID: 42733925 [PubMed]
	Prevalence of High Programmed Death-Ligand 1 Expression in Pulmonary Sarcomatoid Carcinoma: A Systematic Review and Meta-Analysis. JTO Clin Res Rep Hamakawa Y, Shiba A, Noguchi Y, Shinohara H, Higashi Y, Aga M, Miyazaki K, Taniguchi Y, Misumi Y, Agemi Y, Shimokawa T, Okamoto H, Horita N, Nakamura Y. PMID: 42733756 [PubMed]
	Risk factors, incidence, and outcomes of bladder and ureteral cancer in lung transplant recipients: A single-center cohort study. JHLT Open Ahmad S, Hedberg EC, Torri V, Kallingal G, Tokman S. PMID: 42733694 [PubMed]
	Factors Associated with Active Tuberculosis Disease in Patients with Lung Cancer Following Immune Checkpoint Blockade Therapy: A Retrospective Cohort Study and Case Reports. Infect Drug Resist Wang X, Wu YX, Hu WP, Ren Y, Zhang J. PMID: 42733647 [PubMed]
	CT-based deep learning for survival stratification in EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: A multicenter study. iScience Qie S, Shi Y, Li J, Jia S, Liu M. PMID: 42733514 [PubMed]
	Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB-IIIA Non-Small Cell Lung Cancer: Exploratory 8-year Overall Survival Landmark Update from the ADAURA Trial [161/175]. J Thorac Oncol Wu YL, Majem M, John T, Grohé C, Wang J, Goldman JW, Lu S, Shepherd FA, Wang Q, Kato T, Aokage K, Zhong WZ, Laktionov K, Wu MF, Akewanlop C, Vu HV, Lee KH, Huang X, Armenteros-Monterroso E, Rukazenkov Y, Herbst RS. PMID: 42732874 [PubMed - as supplied by publisher]
	Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys Lin SH, Pugh SL, Valle DMD, Roudko V, Edelman MJ, Doemer AJ, Simone CB 2nd, Nie K, Rizakos T, Mugunthan A, Zhang R, Kelly G, Beckmann N, Thompson RC, Schulze SK, Gonzalez-Kozlova E, Gandhi S, Bikkina S, Karim N, Shen X, Badiyan SN, Higgins KA, Chakravarti A, Werner-Wasik M, Schallenkamp JM, Suarez-Farinas M, Gnjatic S, Tsao AS, Bradley JD. PMID: 42731785 [PubMed - as supplied by publisher]
	Bayesian personalized dose constraints in selecting patients with non-small cell lung cancer for cardiac risk-adaptive treatment. Radiother Oncol Chen M, Xu T, Xu T, Maguire RC, Chen X, Koutroumpakis E, Deswal A, Ajdari A, Niedzielski JS, Yang J, Meng QH, Mohan R, Lin R, Zhang X, Liao Z. PMID: 42731758 [PubMed - as supplied by publisher]
	The miR-21-5p-Cell Adhesion Molecule 1 Axis in Non-Small Cell Lung Cancer Progression and Prognosis. J Vis Exp Hu L, Xing Q, Yang H, Xu M. PMID: 42730679 [PubMed - indexed for MEDLINE]
	RAD001-Adjuvanted Influenza Vaccine Synergizes With Anti-Programmed Cell Death Protein 1 Therapy to Enhance Antitumor Immunity in Programmed Cell Death Ligand 1-Low Murine Lung Cancer. World J Oncol Ou HL, Sun J, Wu SB. PMID: 42730473 [PubMed]
	A Mitochondrial-Related Gene Signature for Diagnosis and Immune Microenvironment Modulation in Lung Cancer and Venous Thromboembolism. World J Oncol Zhang XL, Gao AL, Liu ZJ. PMID: 42730163 [PubMed]
	Systematic review of PET imaging features and clinical applications in pulmonary NUT carcinoma. Front Radiol Liu X, Bin L, Zhang Y, Liu H, Gao C. PMID: 42729509 [PubMed]
	Increased reporting of interstitial pneumonitis with combined EGFR-TKI and PD-1/PD-L1 inhibitor therapy in NSCLC: a pharmacovigilance analysis of 67,818 reports. Front Immunol Tao J, Fu Z. PMID: 42729427 [PubMed - indexed for MEDLINE]
	Impact of time-of-day and timing interval of neoadjuvant immunotherapy and chemotherapy infusions among patients with operable NSCLC using the inverse probability of treatment weighting method: a dual-center, retrospective study. Front Immunol Yu XY, Zhai WY, Xia ZZ, Ma K, Zhang BH, Yu X, Lin SC, Guo XT, Zhao ZR, Yu ZT. PMID: 42729373 [PubMed - indexed for MEDLINE]
	Clinical value of combined SHOX2 and RASSF1A methylation in lung cancer diagnosis across tissue and liquid biopsy samples: a systematic review and meta-analysis. Oncol Rev Wang T, Zhang J, Wang J, Dong X, Lin Q, Guo L, Zhang B, Cao Y, Zhai Y, Hadfield M, Hina K, Abbas AE, Ge H, Cheng L, Xing H, Liu Y. PMID: 42729364 [PubMed]

Articles 1 - 20 / 163050

Page 1 of 8153



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy